Allylmercaptocaptopril: A New Antihypertensive Drug

American Journal of Hypertension

Volumn 17, Issue 1, 2004, Pages 71-73

  Miron, Talia ^a   Rabinkov, Aharon ^a   Peleg, Edna ^b,c   Rosenthal, Talma ^b,c   Mirelman, David ^a   Wilchek, Meir ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Allicin; Allylmercaptocaptopril; Captopril; Hyperinsulinemia; Hypertension; Hypertriglyceridemia

Indexed keywords

ALLICIN; ALLYLMERCAPTOCAPTOPRIL; ANTIHYPERTENSIVE AGENT; CAPTOPRIL; FRUCTOSE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DIET SUPPLEMENTATION; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0347320487     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(03)01035-5     Document Type: Article

References (15)

1. Elkayam A, Mirelman D, Peleg E, Wilchek M, Miron T, Rabinkov A, Sadetzki S, Rosenthal T: Comparison of the effects of allicin and enalapril on blood pressure, insulin and triglycerides levels in fructose-induced hyperinsulinemic-hyperlipidemic hypertensive rats. Am J Hypertens 2000;14:377-381.
2. Abramovitz D, Gavri S, Harats D, Levkovitz H, Mirelman D, Miron T, Eilat-Adar S, Rabinkov A, Wilchek M, Eldar M, Vered Z: Allicin-induced decrease in formation of fatty steaks (atherosclerosis) in mice fed on a cholesterol-rich diet. Coron Art Dis 1999;10:515-519.
3. Banerjee A: Effect of aqueous extract of garlic on arterial blood pressure of normotensive and hypertensive rats. Artery 1979;2:369-373.
4. Auer W, Eiber A, Hertkorn E, Hoehfeld E, Koehrle U, Lorenz A, Mader F, Merx W, Otto G, Schmid-Otto B, Taubenheim H: Hypertension and hyperlipidaemia: garlic helps in mild cases. Br J Clin Pract 1990;69(Suppl):3-6.
5. Rabinkov A, Miron T, Konstantinovski L, Wilchek M, Mirelman D, Weiner L: The mode of action of allicin: trapping of radicals and interaction with thiol containing proteins. Biochim Biophys Acta 1998;1379:233-244.
6. Miron T, Rabinkov A, Mirelman D, Wilchek M, Weiner L: The mode of action of allicin: its ready permeability through phospholipid membranes may contribute to its biological activity. Biochim Biophys Acta 2000;1463:20-30.
7. Stoll A, Seebeck E: Chemical investigation on alliin, the specific principle of garlic. Adv Enzymol 1951;11:377-400.
8. Carmel A, Ehrlich-Rogozinsky S, Yaron A: A fluorimetric assay for angiotensin-I converting enzyme in human serum. Clinica Chimica Acta 1979;93:215-220.
9. Reaven GM, Ho H: Sugar-induced hypertension in Sprague-Dawley rats. Am J Hypertens 1991;4:610-614.
10. Erlich Y, Rosenthal T: Contribution of nitric oxide to the beneficial effects of enalapril in the fructose-induced hyperinsulinemic rat. Hypertension 1996;28:754-757.
11. Sowers JR: Impact of lipid and ACE inhibitor therapy on cardiovascular disease and metabolic abnormalities in the diabetic and hypertensive patient. J Human Hypertens 1997;11:9-16.
12. Giatras I, Lau J, Levey AS: Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. Ann Intern Med 1997;127:337-345.
13. Uehara M, Kishikawa H, Isami S, Kisanuki K, Ohkubo Y, Miyamura N, Miyata T. Yano T, Shichiri M: Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: bradykinin may improve insulin resistance in dogs and humans. Diabetologia 1994;37:300-307.
14. Dal Ponte DB, Fogt DL, Jacob S, Henriksen EJ: Interactions of captopril and verapamil on glucose tolerance and insulin action in an animal model of insulin resistance. Metabolism 1998;47:982-987.
15. Russell J, Graham S, Amy R, Dolphin P: Inhibition of myocardial lesions in the JCR: LA-corpulent rat by captopril. J Cardiovasc Pharmacol 1998;31:971-977.